Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

Sirpa Leppa, MD Prof, Judit Jørgensen, MD PhD, Leo Meriranta, MS, Klaus Beiske, MD PhD, Jan M.A. Delabie, MD PhD, Elisabeth Ralfkiaer, MD DMSC, Signe Spetalen, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Harald Holte, MD PhD

Blood (2018) 132 (Supplement 1): 2955.

https://doi.org/10.1182/blood-2018-99-120057

Published: 2018

Journal Articles

The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK , DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

Blood (2017) 130 (Supplement 1): 822.

https://doi.org/10.1182/blood.V130.Suppl_1.822.822

Published: 2017

Journal Articles

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Mareike Frick, Fazila Asmar, Viktor Ljungström, Markus Schneider, Kenichi Yoshida, Aron Skaftason, Tatjana Pandzic, Blanca Gonzalez, Anna Tasidou, Nils Waldhueter, Alfredo Rivas-Delgado, Maria Angelopoulou, Marita Ziepert, Christopher Maximilian Arends, Lucile Couronné, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga D. Munch-Petersen, Thorsten Zenz, Martin-Leo Hansmann, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Martin Erlanson, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Seishi Ogawa, Ralf Küppers, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros P. Vassilakopoulos, Michael Hummel, Richard Rosenquist, Frederik Damm

Blood (2016) 128 (23): 2666–2670.

https://doi.org/10.1182/blood-2016-03-704528

Published: 2016

Includes: Supplemental data

Journal Articles

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, MD, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, MD PhD, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, MD, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**

Blood (2016) 128 (22): 609.

https://doi.org/10.1182/blood.V128.22.609.609

Published: 2016

Journal Articles

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Blood (2016) 128 (22): 1854.

https://doi.org/10.1182/blood.V128.22.1854.1854

Published: 2016

Journal Articles

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, Jan Sundberg, Lone Bredo Pedersen, Elisabeth Ralfkiær, Marja-Liisa Karjalainen-Lindsberg, Christer Sundström, Mats Ehinger, Christian Geisler, Mats Jerkeman

Blood (2016) 128 (14): 1814–1820.

https://doi.org/10.1182/blood-2016-03-704023

Published: 2016

Includes: Supplemental data

Journal Articles

Loss of PRDM11 promotes MYC-driven lymphomagenesis

Cathrine Kolster Fog, Fazila Asmar, Christophe Côme, Klaus Thorleif Jensen, Jens Vilstrup Johansen, Tony Bou Kheir, Linda Jacobsen, Carsten Friis, Alison Louw, Louise Rosgaard, Nina Friesgaard Øbro, Hanne Vibeke Marquart, Kristian Anthonsen, Arie Koen Braat, Maarten van Lohuizen, Elisabeth Ralfkiaer, Kirsten Grønbæk, Anders Henrik Lund

Blood (2015) 125 (8): 1272–1281.

https://doi.org/10.1182/blood-2014-03-560805

Published: 2015

Includes: Supplemental data

Journal Articles

Nordic MCL3 study: 90 Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Blood (2014) 123 (19): 2953–2959.

https://doi.org/10.1182/blood-2013-12-541953

Published: 2014

Journal Articles

Increased Expression Levels Of SOX11 Correlates To Overall Survival and Adds Prognostic Value To The MIPI and MIPI-B Index In a Homogenously Treated Cohort

Lena Nordström, Venera Kuci, Sandra Sernbo, Kirsten Groenbaek, MD, DMSc, Arne Kolstad, Riika Räty, Marja-Liisa Karjalainen, Christian Geisler, Elisabeth Ralfkiaer, MD, DMSc, Christer Sundström, Anna Laurell, Jan Delabie, Mats Ehinger, Mats Jerkeman, Sara Ek

Blood (2013) 122 (21): 4272.

https://doi.org/10.1182/blood.V122.21.4272.4272

Published: 2013

Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc

Blood (2013) 122 (21): 83.

https://doi.org/10.1182/blood.V122.21.83.83

Published: 2013

Journal Articles

Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells

Tine Greve, Erik Clasen-Linde, Morten T. Andersen, Mette K. Andersen, Stine D. Sørensen, Mikkel Rosendahl, Elisabeth Ralfkiær, Claus Yding Andersen

Blood (2012) 120 (22): 4311–4316.

https://doi.org/10.1182/blood-2012-01-403022

Published: 2012

Includes: Supplemental data

Journal Articles

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

Christoffer Hother, MD, Ditte Reker, Konstantions Dimopoulos, MD, Steen Knudsen, PhD, Thomas Jensen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1548.

https://doi.org/10.1182/blood.V120.21.1548.1548

Published: 2012

Journal Articles

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Christoffer Hother, MD, Peter Kristian Rasmussen, MD, Tejal Joshi, PhD, Ditte Reker, Ulrik Ralfkiaer, MSc, Christopher Workman, PhD, Peter De Nully Brown, Steffen Heegaard, Prof. MD, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1600.

https://doi.org/10.1182/blood.V120.21.1600.1600

Published: 2012

Journal Articles

Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin

Blood (2012) 120 (21): 747.

https://doi.org/10.1182/blood.V120.21.747.747

Published: 2012

Journal Articles

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

Blood (2011) 118 (22): 5891–5900.

https://doi.org/10.1182/blood-2011-06-358382

Published: 2011

Includes: Supplemental data

Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Blood (2011) 118 (21): 331.

https://doi.org/10.1182/blood.V118.21.331.331

Published: 2011

Journal Articles

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Ann Brinch Madelung, MD, Michael Bzorek, MT, Henrik Bondo, MD, Eva M.K. Zetterberg, MD, PhD, Ole Weis Bjerrum, MD, DMSc, Hans Carl Hasselbalch, MD, DMSc, Stefan Scheding, MD, Elisabeth Ralfkiaer, Prof., MD, DMSc

Blood (2010) 116 (21): 4108.

https://doi.org/10.1182/blood.V116.21.4108.4108

Published: 2010

Journal Articles

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Blood (2010) 116 (21): 3565.

https://doi.org/10.1182/blood.V116.21.3565.3565

Published: 2010

Journal Articles

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Blood (2010) 116 (21): 3566.

https://doi.org/10.1182/blood.V116.21.3566.3566

Published: 2010

Journal Articles

PRDM11 Is a Novel Putative Tumor Suppressor In Aggressive B Cell Lymphoma

Fazila Asmar, MD, Cathrine Kolster Fog, PhD, M.Sc., Klaus Jensen, PhD, DVM, Linda Jacobsen, PhD, M.Sc., Elisabeth Ralfkiær, Dr.Med, MD, Christian H. Geisler, PhD, MD, Kirsten Gr∅nbæk, Dr.Med., MD, Anders Lund, PhD, M.sc.

Blood (2010) 116 (21): 1002.

https://doi.org/10.1182/blood.V116.21.1002.1002

Published: 2010

NARROW

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK , DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Loss of PRDM11 promotes MYC-driven lymphomagenesis

Nordic MCL3 study: 90 Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Increased Expression Levels Of SOX11 Correlates To Overall Survival and Adds Prognostic Value To The MIPI and MIPI-B Index In a Homogenously Treated Cohort

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

PRDM11 Is a Novel Putative Tumor Suppressor In Aggressive B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only